24
Participants
Start Date
October 1, 2025
Primary Completion Date
October 1, 2027
Study Completion Date
October 1, 2027
Human umbilical cord mesenchymal stem cell injection
Different doses of human umbilical cord mesenchymal stem cell injection were infused to the focus of patients with idiopathic pulmonary fibrosis through bronchoscope, and the tolerance of subjects to different doses of human umbilical cord mesenchymal stem cell injection was observed, and the curative effect was preliminarily observed.
Shanghai Life Science & Technology
INDUSTRY